Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - LONG-TERM DEBT
Long-term Debt IBRX - ImmunityBio, Inc.
721 M
LAST VALUE
37.70%
2 YEAR CAGR
161.10%
5 YEAR CAGR
0.00%
10 YEAR CAGR